Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q57007683
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241121000217.0 |
008
|
|
|
241121nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q57007683
|
024
|
|
|
‡a
0000-0003-1182-4083
‡2
orcid
|
035
|
|
|
‡a
(OCoLC)Q57007683
|
100
|
0 |
|
‡a
Wenju Chang
‡c
researcher
‡9
en
|
400
|
0 |
|
‡a
Wenju Chang
‡c
wetenschapper
‡9
nl
|
670
|
|
|
‡a
Author's A specific KRAS codon 13 mutation is an independent predictor for colorectal cancer metachronous distant metastases
|
670
|
|
|
‡a
Author's Aberrant expression of long noncoding RNAs in colorectal cancer with liver metastasis
|
670
|
|
|
‡a
Author's Anti-EGFR and anti-VEGF agents: important targeted therapies of colorectal liver metastases.
|
670
|
|
|
‡a
Author's Bone Marrow Myeloid Cells Regulate Myeloid-Biased Hematopoietic Stem Cells via a Histamine-Dependent Feedback Loop.
|
670
|
|
|
‡a
Author's CDKL1 promotes tumor proliferation and invasion in colorectal cancer.
|
670
|
|
|
‡a
Author's Depletion of activated hepatic stellate cell correlates with severe liver damage and abnormal liver regeneration in acetaminophen-induced liver injury.
|
670
|
|
|
‡a
Author's Early activated hepatic stellate cell-derived molecules reverse acute hepatic injury
|
670
|
|
|
‡a
Author's Efficacy of continued cetuximab for unresectable metastatic colorectal cancer after disease progression during first-line cetuximab-based chemotherapy: a retrospective cohort study
|
670
|
|
|
‡a
Author's Gastrin and upper GI cancers
|
670
|
|
|
‡a
Author's Gastrin stimulates a cholecystokinin-2-receptor-expressing cardia progenitor cell and promotes progression of Barrett's-like esophagus.
|
670
|
|
|
‡a
Author's Imaging Tiny Hepatic Tumor Xenografts via Endoglin-Targeted Paramagnetic/Optical Nanoprobe
|
670
|
|
|
‡a
Author's Immunohistochemical expression of mTOR negatively correlates with PTEN expression in gastric carcinoma.
|
670
|
|
|
‡a
Author's Isolation and culture of hepatic stellate cells from mouse liver
|
670
|
|
|
‡a
Author's Low tumor infiltrating mast cell density confers prognostic benefit and reflects immunoactivation in colorectal cancer
|
670
|
|
|
‡a
Author's Predictive And Prognostic Value Of Hepatic Steatosis In Conversion Therapy For Colorectal Liver-limited Metastases: A Propensity Score Matching Analysis
|
670
|
|
|
‡a
Author's Randomized Controlled Trial of Intraportal Chemotherapy Combined With Adjuvant Chemotherapy
|
670
|
|
|
‡a
Author's Randomized Controlled Trial of Intraportal Chemotherapy Combined With Adjuvant Chemotherapy (mFOLFOX6) for Stage II and III Colon Cancer.
|
670
|
|
|
‡a
Author's Ribosomal protein S15A promotes malignant transformation and predicts poor outcome in colorectal cancer through misregulation of p53 signaling pathway.
|
670
|
|
|
‡a
Author's Robot-assisted one-stage resection of rectal cancer with liver and lung metastases.
|
670
|
|
|
‡a
Author's Toll-like receptor 4 on islet β cells senses expression changes in high-mobility group box 1 and contributes to the initiation of type 1 diabetes
|
909
|
|
|
‡a
(orcid) 0000000311824083
‡9
1
|
919
|
|
|
‡a
gastrinanduppergicancers
‡A
Gastrin and upper GI cancers
‡9
1
|
919
|
|
|
‡a
immunohistochemicalexpressionofmtornegativelycorrelateswithptenexpressioningastriccarcinoma
‡A
Immunohistochemical expression of mTOR negatively correlates with PTEN expression in gastric carcinoma.
‡9
1
|
919
|
|
|
‡a
imagingtinyhepatictumorxenograftsviaendoglintargetedparamagneticopticalnanoprobe
‡A
Imaging Tiny Hepatic Tumor Xenografts via Endoglin-Targeted Paramagnetic/Optical Nanoprobe
‡9
1
|
919
|
|
|
‡a
gastrinstimulatesacholecystokinin2receptorexpressingcardiaprogenitorcellandpromotesprogressionofbarrettslikeesophagus
‡A
Gastrin stimulates a cholecystokinin-2-receptor-expressing cardia progenitor cell and promotes progression of Barrett's-like esophagus.
‡9
1
|
919
|
|
|
‡a
tolllikereceptor4onisletβcellssensesexpressionchangesinhighmobilitygroupbox1andcontributestotheinitiationoftype1diabetes
‡A
Toll-like receptor 4 on islet β cells senses expression changes in high-mobility group box 1 and contributes to the initiation of type 1 diabetes
‡9
1
|
919
|
|
|
‡a
robotassisted1stageresectionofrectalcancerwithliverandlungmetastases
‡A
Robot-assisted one-stage resection of rectal cancer with liver and lung metastases.
‡9
1
|
919
|
|
|
‡a
ribosomalproteins15apromotesmalignanttransformationandpredictspooroutcomeincolorectalcancerthroughmisregulationofp53signalingpathway
‡A
Ribosomal protein S15A promotes malignant transformation and predicts poor outcome in colorectal cancer through misregulation of p53 signaling pathway.
‡9
1
|
919
|
|
|
‡a
randomizedcontrolledtrialofintraportalchemotherapycombinedwithadjuvantchemotherapymfolfox6forstage2and3coloncancer
‡A
Randomized Controlled Trial of Intraportal Chemotherapy Combined With Adjuvant Chemotherapy (mFOLFOX6) for Stage II and III Colon Cancer.
‡9
1
|
919
|
|
|
‡a
earlyactivatedhepaticstellatecellderivedmoleculesreverseacutehepaticinjury
‡A
Early activated hepatic stellate cell-derived molecules reverse acute hepatic injury
‡9
1
|
919
|
|
|
‡a
efficacyofcontinuedcetuximabforunresectablemetastaticcolorectalcancerafterdiseaseprogressionduring1linecetuximabbasedchemotherapyaretrospectivecohortstudy
‡A
Efficacy of continued cetuximab for unresectable metastatic colorectal cancer after disease progression during first-line cetuximab-based chemotherapy: a retrospective cohort study
‡9
1
|
919
|
|
|
‡a
randomizedcontrolledtrialofintraportalchemotherapycombinedwithadjuvantchemotherapy
‡A
Randomized Controlled Trial of Intraportal Chemotherapy Combined With Adjuvant Chemotherapy
‡9
1
|
919
|
|
|
‡a
predictiveandprognosticvalueofhepaticsteatosisinconversiontherapyforcolorectalliverlimitedmetastasesapropensityscorematchinganalysis
‡A
Predictive And Prognostic Value Of Hepatic Steatosis In Conversion Therapy For Colorectal Liver-limited Metastases: A Propensity Score Matching Analysis
‡9
1
|
919
|
|
|
‡a
specifickrascodon13mutationisanindependentpredictorforcolorectalcancermetachronousdistantmetastases
‡A
A specific KRAS codon 13 mutation is an independent predictor for colorectal cancer metachronous distant metastases
‡9
1
|
919
|
|
|
‡a
aberrantexpressionoflongnoncodingrnasincolorectalcancerwithlivermetastasis
‡A
Aberrant expression of long noncoding RNAs in colorectal cancer with liver metastasis
‡9
1
|
919
|
|
|
‡a
cdkl1promotestumorproliferationandinvasionincolorectalcancer
‡A
CDKL1 promotes tumor proliferation and invasion in colorectal cancer.
‡9
1
|
919
|
|
|
‡a
depletionofactivatedhepaticstellatecellcorrelateswithsevereliverdamageandabnormalliverregenerationinacetaminopheninducedliverinjury
‡A
Depletion of activated hepatic stellate cell correlates with severe liver damage and abnormal liver regeneration in acetaminophen-induced liver injury.
‡9
1
|
919
|
|
|
‡a
antiegfrandantivegfagentsimportanttargetedtherapiesofcolorectallivermetastases
‡A
Anti-EGFR and anti-VEGF agents: important targeted therapies of colorectal liver metastases.
‡9
1
|
919
|
|
|
‡a
lowtumorinfiltratingmastcelldensityconfersprognosticbenefitandreflectsimmunoactivationincolorectalcancer
‡A
Low tumor infiltrating mast cell density confers prognostic benefit and reflects immunoactivation in colorectal cancer
‡9
1
|
919
|
|
|
‡a
bonemarrowmyeloidcellsregulatemyeloidbiasedhematopoieticstemcellsviaahistaminedependentfeedbackloop
‡A
Bone Marrow Myeloid Cells Regulate Myeloid-Biased Hematopoietic Stem Cells via a Histamine-Dependent Feedback Loop.
‡9
1
|
919
|
|
|
‡a
isolationandcultureofhepaticstellatecellsfrommouseliver
‡A
Isolation and culture of hepatic stellate cells from mouse liver
‡9
1
|
996
|
|
|
‡2
NUKAT|n 2015049686
|
996
|
|
|
‡2
LC|n 2009032846
|
996
|
|
|
‡2
LC|n 91028454
|
996
|
|
|
‡2
J9U|987007318115605171
|
996
|
|
|
‡2
ISNI|0000000079832731
|
996
|
|
|
‡2
NKC|utb2012702336
|
996
|
|
|
‡2
NTA|069673144
|
996
|
|
|
‡2
RERO|A023945482
|
996
|
|
|
‡2
ISNI|0000000426641885
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|